Dr Gelareh Zadeh
Targeting clinically challenging meningiomas
Almost a quarter of all primary brain tumours in adults are meningiomas. As many as 90% are low grade meningiomas (Grades 1 and 2) but there is a small subset that are more aggressive (Grade 3).
Meningiomas develop in the membrane that cover and protect the brain and spinal cord. Current treatments depend on the size, location and nature of the tumour, but there are no targeted treatments, yet.
Here are the research projects we are currently funding that relate to understanding or treating meningioma.
Dr Zadeh and the team are investigating what make clinically aggressive meningiomas (CAMs) and radiation induced meningiomas (RIMs) different, and hard to treat.